Schizophrenia Research
Volume 75, Issue 1 , Pages 65-75 , 1 June 2005

Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naïve schizophrenia patients

  • Leonardo Cortese

      Affiliations

    • The University of Western Ontario and Windsor Regional Hospital, Windsor Ontario, Canada
    • ,
  • Michael P. Caligiuri

      Affiliations

    • Department of Psychiatry, The University of California at San Diego, 0603, UCSD, 9500 Gilman Drive, La Jolla, CA 92093, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 858 6421266; fax: +1 858 5527404.
    • ,
  • Ashok K. Malla

      Affiliations

    • McGill University and Douglas Hospital Research Centre, Montreal, Quebec, Canada
    • ,
  • Rahul Manchanda

      Affiliations

    • London Health Sciences Centre, London, Ontario, Canada
    • ,
  • Jatinder Takhar

      Affiliations

    • London Health Sciences Centre, London, Ontario, Canada
    • ,
  • Raj Haricharan

      Affiliations

    • London Health Sciences Centre, London, Ontario, Canada

Received 22 January 2004 ,Revised 8 August 2004 ,Accepted 11 August 2004.

References 

  1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–375
  2. American Psychiatric Association. Diagnostic and Statistical manual of Mental Disorders. fourth edition. Washington, DC: American Psychiatric Association; 1994;
  3. Andreasen NC. Method for assessing positive and negative symptoms. In:  Andreasen N editors. Schizophrenia: Positive and Negative Symptoms and Syndromes. Modern Problems in Pharmacopsychiatry. New York: Karger Publisher; 1990;p. 73–85
  4. Andreasen NC. Improvement of negative symptoms: concepts, definitions and assessment. Int. Clin. Psychopharmacol. 1997;12(Suppl. 2):S7–S10
  5. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997;349:1730–1734
  6. Baumann B, Bogerts B. The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr. Res. 1999;39:141–148
  7. Bradshaw JL. Development Disorders of the Frontostriatal System: Neuropsychological, Neuropsychiatric and Evolutionary Perspectives. Philadelphia: Psychology Press; 2001;
  8. Brown LL, Feldman SM, Smith DM, Cavanaugh JR, Ackermann RF, Graybiel AM. Differential metabolic activity in the striosomes and matrix compartments of the rat striatum during natural behaviors. J. Neurosci. 2002;22:305–314
  9. Busatto GF, Kerwin RW. Schizophrenia, psychosis, and the basal ganglia. Psychiatr. Clin. North Am. 1997;20:897–910
  10. Caligiuri MP. Instrumental measurement of tardive dyskinesia. In:  Yassa R,  Nair NPV,  Jeste DV editor. Neuroleptic-induced Movement Disorders: A Comprehensive Survey. Cambridge University Press; 1997;p. 241–258
  11. Caligiuri MP, Lohr JB. Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin. Neuropharmacol. 1993;16:244–250
  12. Caligiuri MP, Lohr JB. A disturbance in the control of muscle force in neuroleptic-naïve schizophrenia patients. Biol. Psychiatry. 1994;35:104–111
  13. Caligiuri MP, Lohr JB, Jeste DV. Parkinsonism in neuroleptic-naive schizophrenic patients. Am. J. Psychiatry. 1993;150:1343–1348
  14. Caligiuri MP, Lohr JB, Rotrosen J, Adler L, Lavori P, Edson R, et al. Reliability of an instrumental assessment of tardive dyskinesia: results from VA co-operative study #394. Psychopharmacology. 1997;32:61–66
  15. Caligiuri MP, Lohr JB, Ruck RK. Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology. Psychophysiology. 1998;35:431–437
  16. Cannon M, Jones P, Huttunen MO, et al. Motor co-ordination deficits as predictors of schizophrenia among Finnish school children. Hum. Psychopharmacol. Clin. Exp. 1999;14:491–497
  17. Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am. J. Psychiatry. 1995;152:1724–1729
  18. Chouinard G, Ross-Chouinard A, Annable L, et al. The extrapyramidal symptom rating scale. Can. J. Neurol. Sci. 1980;7:233
  19. Cortese L. Movement disorders and clinical correlates in drug-naive, first episode patients with psychosis. Mov. Disord. 2001;16:S51
  20. Csernansky JG, Murphy GM, Faustman WO. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol. Psychiatry. 1991;30:383–400
  21. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13:281–285
  22. Fenn DS, Moussaoui D, Hoffman WF, et al. Movements in never-medicated schizophrenics: a preliminary study. Psychopharmacology. 1996;123:206–210
  23. Fenton WS. Prevalence of spontaneous dyskinesia in schizophrenia. J. Clin. Psychiatry. 2000;61(Suppl. 4):10–14
  24. Fenton WS, Wyatt RJ, McGlashan TH. Risk factors for spontaneous dyskinesia. Arch. Gen. Psychiatry. 1994;51:643–650
  25. Fitzgerald PB, Rolfe TJ, Brewer K, Filia K, Collins J, Filia S, et al. Depressive, positive, negative and parkinsonian symptoms in schizophrenia. Aust. N. Z. J. Psychiatry. 2002;36:340–346
  26. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992;15:133–139
  27. Gervin M, Browne S, Lane A, et al. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am. J. Psychiatry. 1998;155:1202–1206
  28. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch. Gen. Psychiatry. 1993;50:739–750
  29. Graybiel AM, Kimura M. Adaptive neural networks in the basal ganglia. In:  Houk JC,  Davis JL,  Beiser DG editor. Models of Information Processing in Basal Ganglia. Cambridge, MA: MIT Press; 1995;p. 103–106
  30. Jones P, Rodgers B, Murray R, et al. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398–1402
  31. Kopala LC, Good KP, Honer WG. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. J. Clin. Psychopharmacol. 1997;17:308–313
  32. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh: Livingstone; 1919;
  33. Lang DJ, Kopala LC, Vandorpe RA, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am. J. Psychiatry. 2001;158:625–631
  34. Lichter DG, Cummings JL. Frontal–Subcortical Circuits in Psychiatric and Neurologic Disorders. New York: Guildford Press; 2001;
  35. Manschreck TC, Maher BA, Ader DN. Formal thought disorder, the typetoken ratio and disturbed voluntary motor movement in schizophrenia. Br. J. Psychiatry. 1981;139:7–15
  36. Manschreck TC, Maher BA, Rucklos ME, et al. Disturbed voluntary motor activity in schizophrenic disorder. Psychol. Med. 1982;12:73–84
  37. McCreadie RG, Thara R, Kamath S, et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br. J. Psychiatry. 1996;168:221–226
  38. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 1996;50:381–425
  39. Mogensen GH, Jones DL, Yim CJ. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 1980;14:69–97
  40. Mohr F, Hubmann W, Cohen R, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur. Arch. Psychiatr. Neurol. Sci. 1996;246:240–248
  41. Owens DG, Johnstone EC, Frith CD. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch. Gen. Psychiatry. 1982;39:452–461
  42. Pantelis C, Brewer W. Neurocognitive and neurobehavioural patterns and the syndromes of schizophrenia: role of frontal–subcortical networks. In:  Pantelis C,  Nelson HE,  Barnes TRE editor. Schizophrenia: A Neuropsychological Perspective. Chichester, England: John Wiley & Sons; 1996;p. 317–343
  43. Peralta V, Cuesta MJ. Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr. Res. 1999;40:245–253
  44. Peralta V, Cuesta MJ, Martinez-Larrea A, et al. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am. J. Psychiatry. 2000;157:1461–1466
  45. Pfann KD, Buchman AS, Comella CL, Corcos DM. Control of movement distance in Parkinson's disease. Mov. Disord. 2001;16:1048–1065
  46. Robichaud JA, Pfann KD, Comella CL, Corcos DM. Effect of medication on EMG patterns in individuals with Parkinson's disease. Mov. Disord. 2002;17:950–960
  47. Salloway S, Cummings J. Subcortical structures and neuropsychiatric illness. Neuroscience. 1996;2:66–75
  48. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand., Suppl. 1970;212:11–19
  49. Turner T. Rich and mad in Victorian England. Psychol. Med. 1989;19:29–44
  50. Walker E. Attentional and neuromotor functions of schizophrenics, schizoaffectives, and patients with other affective disorders. Arch. Gen. Psychiatry. 1981;38:1355–1358
  51. Walker E, Lewine EJ. Prediction of adult-onset schizophrenia from childhood movies of the patients. Am. J. Psychiatry. 1990;147:1052–1056
  52. Warabi T, Noda H, Yanagisawa N, et al. Changes in sensorimotor function associated with the degree of bradykinesia of Parkinson's disease. Brain. 1986;109:1209–1224
  53. West AR, Grace AA. The role of frontal–subcortical circuits in the pathophysiology of schizophrenia. In:  Lichter DG,  Cummings JL editor. Frontal–Subcortical Circuits in Psychiatric and Neurological Disorders. New York: Guildford Press; 2001;p. 372–400
  54. Whitty P, Clarke M, Browne S, McTigue O, Kamali M, Feeney L, et al. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol. Med. 2003;33:1479–1484
  55. Wolff A-L, O'Driscoll GA. Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients and populations at risk. J. Psychiatry Neurosci. 1999;24:304–314
  56. Yuen O, Caligiuri MP, Williams R, Dickson R. Tardive dyskinesia and positive and negative symptoms of schizophrenia. Br. J. Psychiatry. 1996;168:702–708

PII: S0920-9964(04)00272-5

doi: 10.1016/j.schres.2004.08.003

Schizophrenia Research
Volume 75, Issue 1 , Pages 65-75 , 1 June 2005

Article Tools

* Image Usage & Resolution